22 September
Mirjam te Koppele | Executive Director Quality Assurance, MSD
Mirjam has more than 20 years of experience in the pharmaceutical industry within Research & Development and Quality. She currently works at MSD Biotech in Oss where she is responsible for the quality department and for the release of clinical and commercial products within European legislation.
Before Mirjam joined MSD she was responsible for the quality assurance (GMP/GDP) of the commercial medication and clinical studies (GCP) at Novartis Pharma BV. She previously led the Quality Assurance department within MedImmune/Astra Zeneca and worked at Solvay and Organon.
Mirjam obtained her Bachelor (analytical chemistry) at the Hogeschool Enschede in 1992 and her Masters in Biochemistry at the University of Utrecht in 2003. She completed her Qualified Person training in the United Kingdom.
MSD
MSD is the largest and most versatile pharmaceutical company in the Netherlands. We develop biopharmaceutical innovations with a focus on oncology, hospital care, vaccines and animal health. We do this with about 5,000 employees from our locations in Oss, Haarlem, Boxmeer and De Bilt. We export our medicines and vaccines to more than 140 countries around the world.
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects